About - Nest Genomics

About Us

We are on a mission to make genomics a routine part of patient care.

Our team is made up of product experts, genetic counselors, seasoned engineers and serial entrepreneurs in the genomics space, most recently building Clear Genetics — including the GIA chatbot that served millions of patients — which was acquired by Invitae in 2019.

Product & Strategy

Engineering & Innovation

Alkis Sellis

Engineer
Connect with Alkis Sellis on LinkedIn

Chris Gatzonis

Engineer
Connect with Chris Gatzonis on LinkedIn

Mary Ann Sundermeyer

Engineer
Connect with Mary Ann Sundermeyer on LinkedIn

Brian Cerceo

Engineer

Costas Marino

Engineer
Connect with Costas Marino on LinkedIn

Jordan Garcia

Engineer
Connect with Jordan Garcia on LinkedIn

Dmitry Trifonov

Engineer
Connect with Dmitry Trifonov on LinkedIn

Founder Story

A Personal Beginning

I grew up seeing the power of genetics up close. My father is a pediatric medical geneticist, and my mother is an epidemiologist. Dinner conversations focused on patients and the care they needed. From an early age I listened to stories of families looking for answers. I saw how life-changing genetic information could be—not just for diagnosis, but for understanding, guidance, and hope. I also saw how deeply grateful people were when they finally had access to thoughtful counseling and care.

That stayed with me, and I began sharing these stories with anyone who would listen.

The Gap I Couldn't Ignore

As genetics advanced, the science kept moving faster. New tests became available. Discoveries accelerated. Therapies became more promising, but getting those advances to patients was still far too hard.

Over and over, I saw the same problem: life-changing genetic information existed, but it was not reaching people in routine care. Access depended on where you lived, who your provider was, how much time the clinic had, and whether the right systems were in place. Genetics was advancing quickly, but the infrastructure to deliver it at scale was not.

I became determined to help close that gap.

Building for Access

For the last 20 years, I have focused on building software to make genetic services more accessible. I met my husband, a software engineer, along the way and we've built these companies together.

Our work has included building platforms to support universal carrier screening, and later Clear Genetics and GIA—the Genetic Information Assistant—which was ultimately acquired by Invitae.

Across each chapter of my life, the mission has stayed the same: use technology to make genetics easy to deliver, clear for patients, and available to anyone who wants it.

Learning from the Front Lines

I have had the privilege of working with many incredible teammates. They stayed with me through multiple companies, which allows us to build together from a place of trust. We've worked with forward-thinking providers, health systems, and care teams. By combining forces, we learned the real barriers to bringing genetics to the point of care.

The challenge is not only scientific. It is operational. It is workflow. It is education and follow-up. It is making sure the right patient is identified, the right information is shared, the right test is ordered, and care happens after results come back. These are solvable problems, but only if we build for the realities of healthcare.

Why We Built Nest

We believe technology can help close the gap between breakthrough genetic diagnostics and therapies and the people who need them. We believe genetics should not be a specialty service that reaches only a few. It should be part of everyday care. It should be available to every patient who can benefit from it. Nest exists to help make that possible. We are building the infrastructure to bring genetics into real clinical workflows—so providers can deliver it more easily, and patients can access it more equitably.

Collaborate with us

We built Nest because delivering genomic care at scale is hard: fragmented workflows, limited genetics expertise, and high operational burden. Nest brings smart capabilities into one system—so organizations can launch and scale precision medicine programs, enable timely access to genetic information, and truly focus on patient care.